Cite
Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID‐19 without hydroxychloroquine use: Report of the first case
MLA
Atiye Akbayrak, et al. “Acute Generalized Exanthematous Pustulosis Following Treatment with Favipiravir in a Patient with COVID‐19 without Hydroxychloroquine Use: Report of the First Case.” Journal of Cosmetic Dermatology, vol. 20, June 2021, pp. 2387–89. EBSCOhost, https://doi.org/10.1111/jocd.14304.
APA
Atiye Akbayrak, Mehmet Berati Kalelioglu, Babar K. Rao, Mehmet Atak, & Banu Farabi. (2021). Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID‐19 without hydroxychloroquine use: Report of the first case. Journal of Cosmetic Dermatology, 20, 2387–2389. https://doi.org/10.1111/jocd.14304
Chicago
Atiye Akbayrak, Mehmet Berati Kalelioglu, Babar K. Rao, Mehmet Atak, and Banu Farabi. 2021. “Acute Generalized Exanthematous Pustulosis Following Treatment with Favipiravir in a Patient with COVID‐19 without Hydroxychloroquine Use: Report of the First Case.” Journal of Cosmetic Dermatology 20 (June): 2387–89. doi:10.1111/jocd.14304.